Growth Metrics

GE HealthCare Technologies (GEHC) EPS (Weighted Average and Diluted) (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.85 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 30.89% to $0.85 in Q1 2026 year-over-year; TTM through Mar 2026 was $4.18, a 12.0% decrease, with the full-year FY2025 number at $4.55, up 4.84% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.85 in Q1 2026 for GE HealthCare Technologies, down from $1.29 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.57 in Q4 2024 to a low of $0.41 in Q1 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.98 (2025), compared with a mean of $1.0.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 52.33% in 2023 and later skyrocketed 97.56% in 2024.
  • GE HealthCare Technologies' EPS (Weighted Average and Diluted) stood at $1.22 in 2022, then dropped by 27.05% to $0.89 in 2023, then skyrocketed by 76.4% to $1.57 in 2024, then decreased by 17.83% to $1.29 in 2025, then tumbled by 34.11% to $0.85 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.85 (Q1 2026), $1.29 (Q4 2025), and $0.98 (Q3 2025) per Business Quant data.